BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Deals

Alnylam, Takeda deal

Alnylam received a $10 million milestone payment from Takeda under a May 2008 deal to develop and commercialize RNAi therapeutics to treat cancer and metabolic diseases. The payment was triggered...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >